Revision physician and a § 16
Authors:
J. Štajner
Authors‘ workplace:
Všeobecná zdravotní pojišťovna ČR, Regionální pobočka Hradec Králové
Published in:
Reviz. posud. Lék., 18, 2015, č. 1, s. 20-22
Category:
Review articles, original papers, case report
Overview
The communication analyses the problems of evaluating the remittance of therapeutic remedies by a revision physician according to § 16 of the Law No. 48/1997 Sb. It itemizes the conditions where the evaluation takes place, renders specific documentation and necessary collaboration with the nursing physicians. Legal and ethical problems with the disapproved applications are of considerable extent. There is a missing public and health education in the non-professional and medical public about public health insurance. A revision of the Law No. 48/1997 Sb. has become necessary to comprehensively and univocally define the authorization of the revision physician.
Keywords:
health insurance – § 16 – therapeutic drugs
Sources
1. Zákon č. 48/1997 Sb., o veřejném zdravotním pojištění.
2. Metodika pro pořizování a předávání dokladů VZP ČR.
3. Číselníky léků.
4. AISLP.
5. SPC léčivých přípravků (SÚKL).
Labels
Medical assessment Occupational medicineArticle was published in
Medical Revision
2015 Issue 1
Most read in this issue
- The commitment of physicians to issue Medical report to the patient
- The patient with multiple myeloma in the system of medical and social care in the Czech Republic – assessment of a questionnaire survey
- Revision physician and a § 16
- Functional approach for evaluation of the degree of dependence